0001104659-23-098959.txt : 20230907
0001104659-23-098959.hdr.sgml : 20230907
20230907162608
ACCESSION NUMBER: 0001104659-23-098959
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20230907
DATE AS OF CHANGE: 20230907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luptakova Katarina
CENTRAL INDEX KEY: 0001991149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 231242585
MAIL ADDRESS:
STREET 1: C/O XILIO THERAPEUTICS, INC.
STREET 2: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
tm2325621-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-05
0
0001840233
Xilio Therapeutics, Inc.
XLO
0001991149
Luptakova Katarina
828 WINTER STREET, SUITE 300
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
2.79
2023-09-05
4
A
0
106000
0
A
2033-09-04
Common Stock
106000
106000
D
The option was granted on September 5, 2023 and will vest in equal monthly installments beginning on October 1, 2023 through September 1, 2027.
/s/ Julia Walcott, Attorney-in-Fact
2023-09-07